Newsroom
Press releases and company news from Ten63 Therapeutics.
Ten63 Therapeutics Closes Strategic Financing, Bringing Total Funding to More Than $45M to Scale the Next-Generation of Artificial Intelligent Drug Discovery
Ten63 adds Chugai Venture Fund and the Gates Foundation as new investors, bringing total funding to over $45M to advance its BEYOND drug discovery platform.
Read releaseYosemite's Beverly Lu, Ph.D. joins Ten63's Board of Directors
Ten63 announces its partnership with cancer-focused venture fund Yosemite, and Yosemite's Dr. Beverly Lu joins the company's board of directors.
Read releaseTen63 Therapeutics Elects Steve Hall as Independent Director
Steve Hall, a former Partner at LV Management Group (Lilly Ventures), joins Ten63's board of directors as an independent director.
Read release
